Eloxx Company
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
74210000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership